BBLG
Closed
Bone Biologics Corp
3.68
-0.35 (-8.68%)
Last Update: 01 Jul 2025 23:22:00
Yesterday: 4.03
Day's Range: 3.35 - 4.
Send
sign up or login to leave a comment!
When Written:
0.2585
Bone Biologics Corp is a clinical-stage biotechnology company that develops innovative therapies for bone regeneration and repair. The company's lead product candidate, NELL-1, is a recombinant protein that promotes bone growth and regeneration.
Bone Biologics Corp was founded in 2004 and is headquartered in Burlington, Massachusetts. The company's mission is to develop safe and effective therapies that can help patients with bone fractures, spinal fusion, and other bone-related conditions.
In addition to NELL-1, Bone Biologics Corp has a pipeline of other product candidates in various stages of development. The company is also engaged in research collaborations with leading academic and medical institutions to advance its understanding of bone biology and develop new therapies.
Bone Biologics Corp is a publicly traded company listed on the OTCQB under the ticker symbol "BBLG."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Bone Biologics Corp was founded in 2004 and is headquartered in Burlington, Massachusetts. The company's mission is to develop safe and effective therapies that can help patients with bone fractures, spinal fusion, and other bone-related conditions.
In addition to NELL-1, Bone Biologics Corp has a pipeline of other product candidates in various stages of development. The company is also engaged in research collaborations with leading academic and medical institutions to advance its understanding of bone biology and develop new therapies.
Bone Biologics Corp is a publicly traded company listed on the OTCQB under the ticker symbol "BBLG."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








